'Cures' vs Funding: FDA Appropriations Bill Is Latest Battleground
Executive Summary
The FDA policy reform debate just got more contentious.
You may also be interested in...
FDA Construction Plans Need 'Innovative Financing Options'
Senate Appropriations Committee says agency should look for alternatives to adding more space at its White Oak campus.
FDA Funding Debate Reframed By GAO Reports On Strategic Planning
Republican senators argue reports show that FDA needs significant reform; discussion of Cures and User Fee legislation will now likely focus on what the plan should be.
Orphan Designation Requests To Get Slower Reviews
FDA can't keep pace with requests, placing more pressure on sponsors to ensure submissions are complete.